Strategic Partnerships Quidel has active ecosystem partnerships and a platform-based strategy that enables cross-selling and co-marketing opportunities with analyzer partners and healthcare networks. Target hospitals and clinics that use Beckman Coulter analyzers for BNP testing or multiplex infectious disease panels; propose integrated diagnostic workflows on Savanna; explore joint business development with Beckman Coulter's channel. Leverage these relationships to enter new geographies and expand service contracts.

Point of Care The company emphasizes rapid infectious disease, cardiovascular and metabolic testing at the point of care, aligning with demand from outpatient clinics, urgent care centers, and rural hospitals seeking faster results to improve patient throughput and outcomes. Tailor sales messaging to procurement by Emergency, Primary Care and Laboratory teams that value speed, ease of use, and consistent quality.

Molecular Diagnostics Savanna MDx platform launch and Mesa Biotech acquisition indicate a strategic push into molecular testing. Opportunities exist to offer multiplex PCR panels and companion diagnostic services to mid-sized hospitals, reference labs, and urgent care networks, leveraging Savanna as an integrated workflow from sample to result to EHRs.

Quality Advantage ISO 9001 certification and a formal Conflict Minerals report underscore strong governance and manufacturing quality. Use as a differentiator in RFIs and procurement to justify reliability, favorable lead times, and audit support when contracting with government entities, large health systems, or multi-site networks.

Infectious Disease Partnerships with Global Lyme Alliance demonstrate a focus on infectious diseases and disease awareness. This opens opportunities for targeted Lyme testing programs, public health collaborations, and payer-supported surveillance in tick-endemic regions, offering a path to expand test menus and services.